By Christie Smythe ( March 31, 2009, 12:00 AM EDT) -- In a long-running intellectual property battle over intravascular stents, the U.S. Court of Appeals for the Federal Circuit has largely stood behind a judgment that both Boston Scientific Corp. and Cordis Corp. have infringed certain patent elements, and further closed the door on a claim by Cordis over Boston Scientific's Taxus Liberte stent by dismissing it with prejudice....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.